Early standardized treatment of critical blood pressure elevations is associated with a reduction in eclampsia and severe maternal morbidity
- 1 April 2017
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 216 (4), 415.e1-415.e5
- https://doi.org/10.1016/j.ajog.2017.01.008
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study)Hypertension, 2016
- Use of Maternal Early Warning Trigger tool reduces maternal morbidityAmerican Journal of Obstetrics and Gynecology, 2016
- Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertensionAmerican Journal of Obstetrics and Gynecology, 2016
- 103: Timely assessment and treatment of preeclampsia reduces maternal morbidityAmerican Journal of Obstetrics and Gynecology, 2015
- Reducing maternal mortality from preeclampsia and eclampsia in low‐resource countries – what should work?Acta Obstetricia et Gynecologica Scandinavica, 2014
- Maternal Mortality and Morbidity in the United States: Where Are We Now?Journal of Women's Health, 2014
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991-2003American Journal of Obstetrics and Gynecology, 2008
- Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood PressureObstetrics & Gynecology, 2005
- Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trialThe Lancet, 2002